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Abstract 
 
Leaves paste of Coleus aromaticus is used as a traditional remedy 
for urolithiasis in India. In the present study, the anti urolithiatic 
activity of Coleus aromaticus was investigated in ethylene glycol 
induced urolithiatic rats. There was a significant increase in the 
levels of calcium oxalate crystals in the kidneys as well as lipid 
levels in the blood serum. Treatment with hydro alcoholic extract of 
C.aromaticus leaves (CALHAE) significantly reduced cholesterol 
levels at 300 and 600 mg/kg, and triglyceride levels at 600 mg/kg in 
urolithiatic rats. Histopathalogical reports confirmed that chronic 
administration of CALHAE (300 and 600 mg/kg) diminished 
number of calcium oxalate crystals in kidneys. CALHAE has shown 
reduction in thiobarbituric acid reactive substances (TBARS) in 
urolithiatic rats. Moreover, CALHAE showed potent in vitro 
antioxidant activity in DMPD, ABTS radicals (MnO2 method). 
Results from these studies support the safe and effective use of 
C.aromaticus leaves for urolithiasis treatment. 
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Introduction 
Coleus aromaticus is commonly known as 
country borage. It is a large succulent aromatic 
perennial herb with hispidly villous or tomentose 
fleshy stem. Leaves are simple opposite, broadly 
ovate, crenate, fleshy and very aromatic. The 
leaves of C. aromaticus are often eaten raw with 
bread and butter and it is used for seasoning meat 
dishes and in food products. Decoction of its 
leaves is used in treating chronic cough and 
asthma. Experimentally, leaf oil was exhibited 
activity against microorganisms like fungi and 
bacteria [1]. Both the aqueous and hydro 
alcoholic extracts of C. aromaticus stabilizes 
mast cells in the rat mesenteric tissue [2]. 
Urolithiasis is a common painful condition of 
multifactorial ethiopathogenesis, and calcium 
oxalate (CaOX) is the commonest component of 
upper urinary tract calculi in economically 
developed countries, including North America, 
Europe, Australia, and Japan.   Many 
epidemiological factors, including age, sex, 
heredity, occupation, body size, social class, 
affluence, geographic location, climate, diet and 
fluid intake, have been identified as playing roles 
in kidney stone disease [3]. Oxalate is found in 
many dietary sources, including spinach, rhubarb, 
straw berries, and tea, it is the major kidney stone 
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forming constituent and induces lipid 
peroxidation and alters the lipid profiles, so for 
stone formation, one of the mechanisms was a 
systemic abnormality in lipid metabolism. Stone 
formers are significantly associated with several 
CHD risk factors [4]. Hyperlipidemia associated 
with the nephritic syndrome is a complex 
disorder involving abnormalities most likely 
induced by the glomerular barrier defect [5] 
Furthermore, oxalate increases the production of 
free radicals, which can induce a cell death 
process, crystal deposition in the renal tubules, 
which leads to growth of calcium oxalate stones. 
Human, animal, explants and in vitro studies 
indicate that raised oxidative stress is often 
present in urolithiasis and oxalate per se promotes 
oxidative stress, which is substantially retarded 
by antioxidants [6]. 
 Urolithiasis is largely a recurrent disease 
with a relapse rate of 50% in 5–10 years, thereby 
exists with substantial economic consequences 
and a great public health importance [7]. 
Endoscopic stone removal and extracorporeal 
shock wave lithotripsy have revolutionized the 
treatment of urolithiasis but do not prevent the 
likelihood of new stone formation [8]. Various 
therapies including thiazide diuretics and alkali-
citrate are being used in attempt to prevent 
recurrence of hypercalciuria and hyperoxaluria 
induced calculi but scientific evidence for their 
efficacy is less convincing. The current study 
elucidates the anti urolithiatic and possible 
hypolipidemic activity of C.aromaticus on 
ethylene glycol induced urolithiasis in rats. 
 
Materials and Methods 
Plant collection and extraction 
Fresh leaves of C.aromaticus were collected from 
Herbal Garden and Research center of Acharya 
N.G. Ranga Agricultural University, Rajendra 
nagar, Hyderabad, India.  It was identified and 
authenticated by Dr. R. Mohan Rao, Senior 
Scientist, Office incharge of Herbal garden and 
Research center. The fresh leaves were dried 
under shade and then powdered with mechanical 
grinder. The powder was packed in soxhlet 
column and extracted with methanol and distilled 
water in the ratio of 1:1 for 16 h at 40 ºC. The 
extract was concentrated using rotary flash 
evaporator under reduced pressure and the yield 
was 24% w/w. The dried extract was stored in 
airtight container in refrigerator below 8 ºC. 
 
Experimental animals 
Male wistar rats, weighing between 150-200 g 
were used. These animals were obtained from 
animal house facility of Shadan institute of 
medical sciences and Research Institute. They 
were kept in polypropylene cages with not more 
than five animals per cage and maintained under 
standard laboratory conditions (temperature 25 ± 
2 ºC) in a well-ventilated room under hygienic 
condition, with a dark and light cycle of (12 h 
each). The animals were fed with extruded 
pelleted rat/mouse feed manufactured by Rayans 
Hyderabad Pvt. Ltd., were provided ad libitum. 
The study was approved by Shadan College of 
Medical Sciences and Research Institute, Shadan 
College of Pharmacy, Institutional Animal 
Ethical Committee. 
 
Chemicals and Reagents 
Ethylene glycol, ammonium chloride, 
trichloroacetic acid, thiobarbituric acid, linoleic 
acid, ammonium thiocyanate, ferrous chloride, 
butylated hydroxy toluene, α-tocopherol, 
ammonium molybdate, ascorbic acid, ABTS 
([2,2-azinobis (3-ethyl benzothiazoline-6-sulfonic 
acid) diammonium salt]) and DMPD (N,N-
dimethyl-p-phenylene diamine ) were obtained 
from Sigma Chemical Company, St. Louis, MO, 
and USA. Hydrochloric acid, potassium chloride, 
manganese dioxide, ferric chloride, sulphuric acid 
and sodium phosphate were purchased from 
NICE Chemicals Pvt. Ltd., Cochin. Disodium 
hydrogen phosphate, potassium dihydrogen 
phosphate and sodium hydroxide were purchased 
from Merck  (India) Ltd., Mumbai. 
 
In vitro total antioxidant capacity  
Total antioxidant capacity was determined by 
following a procedure similar to that of [9]. 
Different concentrations of CALHAE and 
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ascorbic acid (ASC) are mixed separately with 3 
ml of reagent solution (0.6 M sulphuric acid, 28 
mM sodium phosphate and 4 mM ammonium 
molybdate), incubated at 95 °C for 90 min, 
cooled to room temperature and absorbance was 
measured at 695 nm. Plotting the absorbance 
against ASC concentration gave the linear curve 
with a correlation coefficient (r2 = 0.996). Total 
antioxidant capacity was expressed as the number 
of equivalents of ascorbic acid (ASC) using 
standard plot. 
 
In vitro ABTS.+  radical inhibition (MnO2 method)   
Antioxidant activity was determined following a 
procedure similar to that of [10]. The ABTS+ 
radical cation was generated by filtering a 
solution of ABTS in PBS through manganese 
dioxide powder. Excess manganese dioxide was 
removed from the filtrate by passing it through a 
0.2 μ syringe filter, this solution was diluted in 5 
mM PBS pH 7.4, adjusted to an absorbance of 
0.700 at 734 nm and pre-incubated at room 
temperature prior to use for 2 h. 1 ml of the 
ABTS+ solution & 200 μL solution of 
antioxidants were vortexed for 30 s, centrifuged 
for 60 s at 10,000 rpm. Absorbance was recorded 
at 734 nm. Solvent blanks were run in each assay. 
The antioxidant activity of the substances was 
calculated by determining the decrease in 
absorbance at different concentrations by using 
the following equation.   
%  ABTS.+ scavenging activity = [(Control absorbance -
Extract absorbance) / (Control absorbance) ]*100 
 
In vitro linoleic acid peroxidation inhibition, 
Ferric thiocyanate (FTC) method  
The standard method as described by Kikuzaki 
and Nakatani [11] was used. A mixture of 4 mg 
of plant extract in 4 ml of absolute ethanol, 4.1 
ml of 2.52% linoleic acid in absolute ethanol, 8.0 
ml of 0.05 M phosphate buffer (pH 7.0), and 3.9 
ml of water was placed in a vial with a screw cap 
and then placed in a dark oven at 40 °C. To 0.1 
ml of this solution 9.7 ml of 75% ethanol and 0.1 
ml of 30% ammonium thiocyanate were added. 
Precisely 3 min after the addition of 0.1 ml of 
0.02 M ferrous chloride in 3.5% HCl to the 
reaction mixture, the absorbance of red color was 
measured at 500 nm every 24 h until one day 
after the absorbance of control reached its 
maximum. Butylated hydroxy toluene (BHT) and 
α-tocopherol were used as positive controls, 
while a mixture without a plant sample was used 
as the negative control. 
 
In vitro DMPD radical inhibition   
DMPD, 100 mM was prepared by dissolving 209 
mg of DMPD in 10 ml of deionized water, 1 ml 
of this solution was added to 100 ml of 0.1 M 
acetate buffer, pH 5.25, and the colored radical 
cation (DMPD+) was obtained by adding 0.2 ml 
of a solution of 0.05 M ferric chloride (final 
concentration 0.1 mM). 1 ml of this solution was 
directly placed in a 1 ml plastic cuvette and its 
absorbance at 505 nm was measured. An optical 
density of 0.900 absorbance was obtained and it 
represents the uninhibited signal. The optical 
density of this solution, which is freshly prepared 
daily, is constant up to 12 h at room temperature. 
Standard solutions of the different antioxidant 
compounds were prepared as follows: 1 mg/ml of 
ascorbic acid was prepared by dissolving 0.1 g of 
ascorbic acid in 100 ml of deionized water. 
Extract solutions concentration was 6 mg/ml.50 
µl of extract solution was added to 1 ml of 
DMPD solution, after that mixed properly for 10 
min and recorded absorbance at 505 nm [12]. 
 %  DMPD scavenging activity = [(Control absorbance -
Extract absorbance) / (Control absorbance)]*100 
 
In vivo experimental design 
Antiurolithiatic activity of CALHAE was 
determined by using ethylene glycol induced 
hyperoxaluria model as described with some 
modifications was used to assess the 
antiurolithiatic activity in albino rats. Animals 
were divided into five groups containing six 
animals in each. Group I served as control and 
received free access regular rat food and drinking 
water. Ethylene glycol (0.75%) in drinking water 
was provided to Groups II–V for induction of 
renal calculi for 28 days. Group III received 
standard antiurolithiatic drug cystone (500 
mg/kg) from day 15 to 28 [13]. Groups IV and V 
served as curative regimen (CR). Group IV 
received CALHAE (300 mg/kg) and Group V 
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received CALHAE (600 mg/kg) at dose volume 
of 2 ml/kg through oral route of administration 
from day 15 to 28. On day 0, 7 and 15 using 
metabolic cages 24 h urine of ethylene glycol 
treated rats was collected, centrifuged at (2,500 
rpm for 10 min) and subjected to microscopic 
analysis for the conformation of the stone 
formation [14]. 
Blood samples were collected on day 28 through 
retro orbital plexus of rats under ether anesthesia 
using a glass capillary tube after 12 h fasting and 
the blood was centrifuged (4,000 rpm for 10 min) 
to get serum. Biochemical estimation of total 
cholesterol (TC), HDL, LDL and triglyceride 
(TG) was done with the help of kit-based 
methods by using semi autoanalyser (Star plus). 
The abdomen was cut opened to remove both 
kidneys from each animal. Isolated kidneys were 
cleaned off from extraneous tissue and rinsed in 
ice-cold physiological saline. The right kidney 
was fixed in 10% neutral buffered formalin, 
processed in a series of graded alcohol and 
xylene, embedded in paraffin wax, sectioned at 5 
µm and stained with H and E (Haematoxylin and 
Eosin) for histopathological examination. The 
slides were examined under light microscope to 
study light microscopic architecture of the kidney 
and calcium oxalate deposits. The left kidney was 
finely minced and 10% homogenate was prepared 
in Tris–HCl buffer (0.02 mol/l, pH 7.4) and was 
used to estimate thiobarbituric acid reactive 
substance s (TBARS) [15]. 
 
Statistical analysis 
The results of biochemical estimation were 
reported as mean ± standard error of mean 
(S.E.M). The data was analysed by (Graph Pad 
Prism, 4 Version) One-way analysis of variance 
(ANOVA). Differences among the means were 
analysed by Dunnett’s posthoc test and p < 0.05 
was considered significant. 
Results  
In vitro linoleic acid peroxidation inhibitory 
activity 
The antioxidant activities of CALHAE in 
preventing the peroxidation of linoleic acid, as 
measured by thiocyanate method, are shown in 
Table 1. Absorbance of control increased up to 
1.845 at 168 h. This is due to oxidation of linoleic 
acid, generating linoleic acid hydroperoxides, 
which leads to many secondary oxidation 
products [16]. The oxidized products (namely, 
linoleic acid hydroperoxides) react with ferrous 
chloride to form ferric chloride, then to ferric 
thiocyanate (blood red color). In the presence of 
CALHAE and BHT, oxidation of linoleic acid 
was very slow. Hence, the color development is 
slow. 
 
In vitro total antioxidant capacity (TAC) 
The assay is based on the reduction of 
molybdate-VI (MoVI) to molybdate-V (MoV) by 
the extract and subsequent formation of a green 
phosphate/MoV complex in acidic pH.  Activity 
was expressed as the number of equivalents of 
ascorbic acid (ASC) using standard plot. Here 
CALHAE was found to possess potent 
antioxidant capacity (reduction of MoVI to MoV) 
of 8 µg of ASC equivalents per 175 µg of the 
CALHAE (Table 2). 
Table 1: 
CALHAE conc.     Absorbance of the reaction mixture at 500 nm in different days 
(mg/mL)                  Day1        Day2        Day3       Day4       Day5       Day6         Day7 
1 mg                        0.212        0.235       0.243       0.244      0.248        0.251        0.26 
2 mg                        0.178        0.198       0.205       0.21        0.219        0.221        0.228 
3 mg                        0.153        0.18         0.184       0.186      0.195        0.201        0.206 
BHT-1 mg               0.122        0.124       0.127       0.129      0.131        0.135        0.138 
Control                    0.388        0.669       0.807       0.985      1.151        1.412        1.845 
 
287 
 
Venkatesh et al. International Journal of Phytomedicine 2 (2010) 284-291 
 
Ta     ble 2:  
Method CALHAE  (IC50 in µg) 
Ascorbic acid 
(IC50 in µg) 
Total antioxidant 
assay  - number of 
equivalents of 
ascorbic acid  
175  8  
ABTS radical 
inhibition  9.1  3.7  
DMPD radical 
inhibition  148  33  
 
In vitro ABTS.+  radical inhibitory activity   
ABTS (2, 2’-azinobis-3-ethylbenzothiozoline-6-
sulphonic acid) assay is based on the scavenging 
of light by ABTS radicals. An antioxidant with an 
ability to donate a hydrogen atom will quench the 
stable free radical, a process that is associated 
with a change in absorption that can be followed 
spectrophotometrically. The relatively stable 
ABTS radical has a green color and was 
quantified spectrophotometrically at 734 nm. 
Here CALHAE showed an appreciable 
antioxidant activity of 50 % at 9.1 µg/ml, while 
ascorbic acid shown 50% antioxidant activity at 
3.7 µg/ml (Table 2). 
 
In vitro DMPD radical inhibitory activity   
Mainly DMPD•+ assay was based on generation 
of a violet colored radical cation resulting from 
the reaction of DMPD with FeCl3 at an acidic pH. 
The extent of decolorization on addition of 
standard/sample solutions to DMPD•+ was 
determined in terms of percentage inhibition. The 
method is applicable to the study of both water-
soluble and lipid-soluble antioxidants, pure 
compounds, and food extracts. The CALHAE 
showed a concentration-dependent antiradical 
activity by inhibiting DMPD radical with an IC50 
value of 148 µg/ml and ascorbic acid IC50 was 33 
µg/ml (Table 2).  
 
Anti urolithiatic effect of CALHAE in ethylene 
glycol induced urolithiatic rats  
Administration of ethylene glycol induced 
urolithiasis and resulted in elevation of lipid 
parameters like serum cholesterol, triglyceride, 
HDL and LDL (p<0.01). CALHAE significantly 
reduced the cholesterol at 300 mg/kg (p<0.05) 
and 600 mg/kg (p<0.01) dose levels. It also 
reduced triglyceride levels in urolithiatic rats, but 
statistical significance was reached at 600mg/kg 
dose (p<0.05) (Table 3).  Both cystone and 
CALHAE had no effect on HDL and LDL levels 
(Table 4). In rats, ethylene glycol induced 
urolithiasis and related oxidative changes. Both 
CALHAE and cystone have reduced the 
thiobarbituric acid reactive substances 
significantly (p<0.01) in the kidney (Table 4). 
Vehicle treated rat kidney tissue was devoid of 
calcium oxalate crystals In contrast Ethylene 
glycol induced urolithiasis rat kidney which was 
evident through shown the deposition of calcium 
oxalate crystals (Figs. 1a, 1b) in medulla region 
and in renal tubules, which are large polyclonal 
crystals. The urolithiatic rats treated with 
CALHAE (300 and 600 mg/kg) have shown 
reduction in the number of calcium oxalate 
crystals (Figs. 1c, 1d) in medulla region after 15 
days treatment, as equiefficacious to cystone 
treatment at 500 mg/kg dose level (Fig. 1e). 
 
Table 3:  
Groups           Serum Total             Triglycerides     
        Cholesterol      (mg/dl) 
           (mg/dl)         
 I               77.95  ± 0.98 b      77.4 ± 1.45 b  
II     116.7 ± 1.5        100.2 ± 1.38  
III     92.55 ± 2.09 b       94.4  ± 2.74  
IV     109.9  ± 1.69 a       98.4 ± 1.50 
V              91.37  ± 2.16 b               92.5 ± 1.63 a  
Group I (Sham control), Group II (Urolithiatic Control), Group III 
(Cystone 500 mg/kg), Group IV (CALHAE 300 mg/kg), Group V 
(CALHAE 600 mg/kg).  
ap<0.05, bp<0.01 One way ANOVA followed by Dunnett’s 
posthoc test (n=6) as compared with group II. 
Discussion 
In the present study male rats were chosen 
because they bear a resemblance to human 
urinary system [17] and some earlier studies 
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have also shown that the amount of stone 
deposition in female rats was significantly less 
[18]. Long-term administration of ethylene 
glycol induced urolithiasis and related oxidative 
changes in these rats.  
The interesting finding of our study was the 
observation of high concentration of total 
cholesterol, triglycerides and LDL levels in 
serum of ethylene glycol induced urolithiatic 
rats. Administration of CALHAE significantly 
reduced the cholesterol and triglyceride levels in 
serum whereas both the doses did not show 
reduction in LDL levels and improvement in 
HDL levels. Moreover elevated serum 
cholesterol and triglycerides levels did not cause 
glucose intolerance in urolithiatic rats, which 
was confirmed by oral glucose tolerance test 
(OGTT). From the histopathological studies, it 
was clearly observed that vehicle treated rat 
kidney tissue was devoid of calcium oxalate 
crystals. In contrast ethylene glycol induced 
urolithiatic rat kidney tissues shown the 
deposition of calcium oxalate crystals in medulla 
region and in renal tubules, which are large 
polyclonal crystals. The urolithiatic rats treated 
with CALHAE have shown reduction in the 
number of calcium oxalate crystals in medulla 
region after 15 days treatment, as equiefficacious 
to cystone treatment.  The serum lipid profile is 
generally considered as a reflection of the tissue 
metabolism and the permeability of cell 
membrane to various ions, which in turn depends 
on lipid composition [19]. It has been reported 
that hyperlipidemia is secondary cause to 
nephrolithiasis, and it can aggravate the primary 
renal disorder [20]. Hyperlipidemia has an 
adverse effect on glomerular function on normal 
and experimental animals [21]. Serum total 
cholesterol was raised in the stone forming rats 
[22]. 
Table 4: 
Groups  LDL (mg/dl)  HDL (mg/dl)            TBARS (nM/mg) 
  I    16.6 ± 0.48 b    42.62 ± 1.54 b              -- 
 II    25.08 ± 0.73       32.08 ± 1.70            291.02 ± 13.8 
 III    22.45 ± 0.86        34.12 ± 1.32            174.6 ± 13.01 b  
IV    24.33 ± 1.60   31.53 ± 0.93         189.7± 14.3 b  
V          24.05 ± 0.58        33.32 ± 1.18            153.5 ± 10.8 b 
Group I (Sham control), Group II (Urolithiatic Control), Group III (Cystone 500 mg/kg), Group IV (CALHAE 300 mg/kg), Group V 
(CALHAE 600 mg/kg). TBARS: Thiobarbituric acid reactive substance.  
The abundance of polyunsaturated fatty acids 
(PUFA) makes the kidney an organ particularly 
vulnerable to reactive oxygen species (ROS) 
attack [23]. ROS causes hyperlipoproteinemia 
and lipoprotein nephropathy through fibrosis, 
inflammation, Lipid peroxidation, and 
antioxidant enzyme modulation [24]. Oxidative 
stress may be caused by increased concentrations 
of free oxalate ions or by insoluble calcium 
oxalate interacting directly with renal epithelial 
cells, or may originate from other inflammatory 
events. Exposure to high concentrations of 
oxalate can induce oxidative stress, as shown by 
increased lipid peroxidation  [25]. In the current 
study, increased TBARS levels in the ethylene 
glycol induced urolithiatic rats were observed 
and treatment with CALHAE and cystone has 
reduced the TBARS levels.   
Results form our in vitro and in vivo studies 
demonstrated that exposure to high lipid levels 
results in greater production of ROS, leading to 
lipid peroxidation and the inhibitory effect of 
CALHAE on calcium oxalate crystals in the 
kidney. 
 
Conclusion  
In the present study administration of the 
CALHAE has reduced the growth of kidney 
stones in ethylene glycol induced urolithiatic rats, 
supporting folk information regarding 
antiurolithiatic activity of C.aromaticus. Anti 
hyperlipidemic and potent antioxidant properties 
of C.aromaticus could be of great significance in 
diminution of calcium oxalate crystals formation 
in the kidney. Further long-term studies are 
warranted to clarify the mechanism and 
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C.aromaticus can play a vital role in urolithiasis 
therapy.  
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